coronavirus (COVID-19 or SARS-CoV-2) resources for research & lab professionals

Virtual research studies, clinical trials & surveys are possible
during the coronavirus pandemic with Mitra® - our remote
specimen collection devices powered by VAMS® technology!

In the US, use of the Mitra device with blood is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device is approved as a remote blood sample collection device for some clinical applications, as referenced in the content included here.

News Update: NIH Uses Remote Specimen Collection Kits From Neoteryx in Study to Track Undetected Cases of Coronavirus Infection.
q2-NIH-article-highlight-resource-page-3-1

Ready to go virtual? 
Explore the resource tabs below to find the tools & information you need. 

News | NIH Begins Study to Quantify Undetected Cases of Coronavirus Infection 

In this “SeroSurvey,” researchers will collect blood samples using Mitra blood collection kits from Neoteryx and analyze those samples from 10,000 volunteers to provide critical data for epidemiological models. Results will examine antibodies against COVID-19 and help illuminate the extent to which the novel coronavirus has spread undetected.

Read Now →

Tutorial | Taking a Specimen Sample with a Mitra Device Powered by VAMS Technology 

 

Webinar | Immunoassays: Extraction Methods That You Can Use With Dried Specimen Samples

Neoteryx’s Technical Director highlights  several study papers in peer-reviewed publications to provide a summary of research studies using extraction methodology for Mitra remote specimen sampling devices in ligand binding assays.

Research Papers | VAMS Microsampling Technology

Over one hundred peer-reviewed publications validate compatibility of VAMS remote specimen technology with a variety of analytes, including biomarkers, DNA/RNA, drugs, metals, and more. 

Download Now →

Tech Brief | Review of Mitra Extraction Methods For Immunoassays

Laboratories around the world are rapidly developing immunoassays for COVID-19. This mini-review looks at a number of papers detailing successful onboarding of Mitra® microsampling devices for a variety of analytes including immunoglobulins.
 

Download Now →

News | University of Rochester Uses Mitra Home Collection Kits for Study

As researchers around the world race to respond to the COVID-19 pandemic, UR CTSI Co-Director Martin Zand, M.D., Ph.D., is rapidly adapting previous research to develop a potential diagnostic test that would require just a few drops of blood to detect the fast-spreading disease.

Read Now →

Research Paper | Application of VAMS to measure multidimensional anti-influenza IgG antibodies by the mPlex-Flu assay

This study successfully measures immunity for up to 33 strains of influenza virus. Twenty-one healthy volunteers were used to evaluate the feasibility of combining the benefits of at-home specimen sampling, with the mPlex-Flu assay.

Download Now →

News | 1,000 North Carolina Patients Will Get an Antibody Test to See if They’ve Had Coronavirus

Wake Forest Baptist Health will begin a year-long random sample of its patients looking for coronavirus antibodies, an attempt to get a sense of how widespread the virus is and was in North Carolina. Neoteryx specimen collection kits will be used in the study to sample 300 people in each of 40 counties — 20 served by Wake Forest Baptist Health and 20 served by Atrium — to build a large enough population.

Read Now →

Webinar | Application of VAMS to measure Flu antibodies by the mPlex-Flu assay

Neoteryx’s Technical Director highlights the study details of the paper: Wang J, et. al (2019) Application of VAMS to measure multidimensional anti-influenza IgG antibodies by the mPlex-Flu assay. Journal of Clinical and Translational Science, 3: 332–343.

 

Video | The Promise of Remote Sampling for Monitoring Viral Pathogens

 

Study Enrolling | Phosphorous Labs 

Phosphorous is currently enrolling research participants in its study focused on validation of at-home collection of specimen samples that will be sent back to the lab and used for the diagnosis of COVID-19 Infection via RT-qPCR and serum antibodies.

Enroll Here →

Webinar | Specimens Collected on a VAMS Device for Monitoring HCQ 

Neoteryx’s Technical Director highlights the study details of the paper: Qu. Y, et. al (2017) Capillary Specimen Collected on a Volumetric Absorptive Microsampling (VAMS) Device for Monitoring Hydroxychloroquine in Rheumatoid Arthritis Patients. Journal of Pharmaceutical and Biomedical Analysis, 140: 334–341.

 

Blog | Cytokines As Predictive Biomarkers of Severe COVID-19: Could At-Home Sampling Be Helpful?

Blood flowing through vein in blue

It is thought that inflammation and cytokines play a role in COVID-19 illness, and our understanding of this will inform how we can treat COVID-19 patients.

Read Now →

The Mitra Microsampler
Safe, Simple, Precise.

mitra-cartridge-microsampler

Cartridge

This easy-to-use format has two sampling devices, includes barcoding, and is enclosed in a specimen bag for convenient transport.

mitra-clamshell-dry-blood-micro-sampling-device_v2

Clamshell

This low-budget specimen collection format works well for pilot studies, proof-of-concept testing, and clinical research with limited funding.

mitra-96-autorack

96-Autorack

The 96-autorack enables high throughput sample processing for liquid extractions, analytical method development, and setting up QCs/Calibrators.

remote-clinical-blood-collection-kit-utilizing-mitra-cartridge

Collection Kits

The Clamshell and Cartridge Mitra formats are available packaged in collection kits that include instructions, lancets, and other supplies. Kits can be customized to your needs.

Neoteryx created the Mitra® Microsampler with you in mind.
Whether you are a research scientist, clinical trial manager, lab director or technician, there is a Mitra Microsampler that will work for you.
We'll help you select the device format that fits you best via a quick conversation with a Microsampling Consultant.

 

 

 

 

 

 

Want to Learn More? 

Read more about our Mitra® and VAMS® technologies or get in touch with us! 

Request PricingContact Us

Fuel Your Innovative Approach to Science & Research. Subscribe to Our Microsampling Newsletter!

Get Our Newsletter

 

Get in Touch

 

Neoteryx, LLC

© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501

This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.

Get To Know Us

Follow Us

Mitra® is an exempt medical device in the US, CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, and registered with Health Canada. It is intended as a specimen collector and for the storage and transport of biological fluids. Use of the device with blood for diagnostic applications is limited to certain countries and, in the US, for research and non-diagnostic purposes only. Neoteryx Products are not marketed in the US for clinical diagnostic uses. In other countries, Neoteryx Products may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Neoteryx operates a Quality Management System (QMS) that is based on FDA good manufacturing practices, 21 CFR 820 regulations, and ISO-13485.

Copyright © 2020 Neoteryx, LLC. All rights reserved.